Kalayoglu Murat 4
4 · Cartesian Therapeutics, Inc. · Filed Jan 6, 2025
Insider Transaction Report
Form 4
Kalayoglu Murat
Director10% Owner
Transactions
- Award
Common Stock
2025-01-02+2,600→ 508,977 total - Award
Stock Option (Right to Buy)
2025-01-02+7,800→ 7,800 totalExercise: $16.93From: 2026-01-02Exp: 2035-01-01→ Common Stock (7,800 underlying)
Holdings
- 4,555,260(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of common stock, which will vest in full on January 2, 2026.
- [F2]Shares are held in a trust (the "Trust") for the benefit of the reporting person's spouse and children. The reporting person's spouse is a trustee of the trust.